Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina DiPrimio

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Opinion in Molecular Therapeutics|October 2, 2010
Adeno-associated virus for the treatment of muscle diseases: toward clinical trialsNina DiPrimio, Scott W J McPhee, R Jude Samulski
Journal of Virology|March 28, 2008
Surface loop dynamics in adeno-associated virus capsid assemblyNina DiPrimio, Aravind Asokan, Lakshmanan Govindasamy, et al.
Journal of Virology|April 17, 2009
Cytotoxic-T-lymphocyte-mediated elimination of target cells transduced with engineered adeno-associated virus type 2 vector in vivoChengwen Li, Matt Hirsch, Nina DiPrimio, et al.
Journal of Virology|June 25, 2010
Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transductionJarrod S Johnson, Chengwen Li, Nina DiPrimio, et al.
G3 (Bethesda, Md.)|December 12, 2018
Yeast Models of Phosphomannomutase 2 Deficiency, a Congenital Disorder of GlycosylationJessica P Lao, Nina DiPrimio, Madeleine Prangley, et al.
Journal of Natural Products|September 7, 2018
GEX1A, a Polyketide from Streptomyces chromofuscus, Corrects the Cellular Defects Associated with Niemann-Pick Type C1 in Human FibroblastsEve A Granatosky, Nina DiPrimio, Jarred R E Pickering, et al.
Journal of Virology|May 18, 2012
Single amino acid modification of adeno-associated virus capsid changes transduction and humoral immune profilesChengwen Li, Nina Diprimio, Dawn E Bowles, et al.
Disease Models & Mechanisms|October 17, 2019
Drug screens of <i>NGLY1</i> deficiency in worm and fly models reveal catecholamine, NRF2 and anti-inflammatory-pathway activation as potential clinical approachesSangeetha Iyer, Joshua D Mast, Hillary Tsang, et al.
Disease Models & Mechanisms|October 23, 2019
Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDGSangeetha Iyer, Feba S Sam, Nina DiPrimio, et al.
Journal of the American Chemical Society|December 10, 2013
The designability of protein switches by chemical rescue of structure: mechanisms of inactivation and reactivationYan Xia, Nina DiPrimio, Theodore R Keppel, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Molecular Therapeutics|October 2, 2010
Adeno-associated virus for the treatment of muscle diseases: toward clinical trialsNina DiPrimio, Scott W J McPhee, R Jude Samulski
Journal of Virology|March 28, 2008
Surface loop dynamics in adeno-associated virus capsid assemblyNina DiPrimio, Aravind Asokan, Lakshmanan Govindasamy, et al.
Journal of Virology|April 17, 2009
Cytotoxic-T-lymphocyte-mediated elimination of target cells transduced with engineered adeno-associated virus type 2 vector in vivoChengwen Li, Matt Hirsch, Nina DiPrimio, et al.
Journal of Virology|June 25, 2010
Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transductionJarrod S Johnson, Chengwen Li, Nina DiPrimio, et al.
G3 (Bethesda, Md.)|December 12, 2018
Yeast Models of Phosphomannomutase 2 Deficiency, a Congenital Disorder of GlycosylationJessica P Lao, Nina DiPrimio, Madeleine Prangley, et al.
Journal of Natural Products|September 7, 2018
GEX1A, a Polyketide from Streptomyces chromofuscus, Corrects the Cellular Defects Associated with Niemann-Pick Type C1 in Human FibroblastsEve A Granatosky, Nina DiPrimio, Jarred R E Pickering, et al.
Journal of Virology|May 18, 2012
Single amino acid modification of adeno-associated virus capsid changes transduction and humoral immune profilesChengwen Li, Nina Diprimio, Dawn E Bowles, et al.
Disease Models & Mechanisms|October 17, 2019
Drug screens of <i>NGLY1</i> deficiency in worm and fly models reveal catecholamine, NRF2 and anti-inflammatory-pathway activation as potential clinical approachesSangeetha Iyer, Joshua D Mast, Hillary Tsang, et al.
Disease Models & Mechanisms|October 23, 2019
Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDGSangeetha Iyer, Feba S Sam, Nina DiPrimio, et al.
Journal of the American Chemical Society|December 10, 2013
The designability of protein switches by chemical rescue of structure: mechanisms of inactivation and reactivationYan Xia, Nina DiPrimio, Theodore R Keppel, et al.
Pageof 2